OhioHealth Molecular Tumor Board 2020 - OhioHealth - Continuing Education (CE)

OhioHealth providers and associates only - click Sign in with Your OhioHealth ID. All others - please login with the email address you used to register with earlier.

Enter Your Information. *All fields are required.

Select Degree:

Select Profession:

*Profession can be updated in the “My Profile” area

Select Primary Credit Eligibility:

*Additional credit eligibilities can be updated in the “My Profile” area

Empty Box that can be used later for a new control but makes the formatting work now instead of a bunch of random CSS

Go Back to Login button

Go Back to Login

OhioHealth Molecular Tumor Board 2020

Add to Calendar OhioHealth Molecular Tumor Board 2020 1/3/2020 7:00:00 AM 1/3/2020 8:00:00 AM America/New_York OhioHealth Arthur G.H. Bing, MD, Cancer Center false MM/DD/YYYY

Occurs monthly on the 1st Friday starting on 1/3/2020 at 7:00 AM, OhioHealth Arthur G.H. Bing, MD, Cancer Center, Columbus, OH

Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology

The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment.

Objectives

Analyze genomic alterations included on genomic test report for potential drug targetability.
Analyze genomic alterations included on genomic test report for potential drug targetability.
Evaluate treatment options based genomic testing in a multidisciplinary, case-based approach
Evaluate treatment options based genomic testing in a multidisciplinary, case-based approach

OhioHealth is accredited by the Ohio State Medical Association (OSMA) to provide continuing medical education to physicians.

OhioHealth designates this Live Activity activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OhioHealth Doctors Hospital is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians

Sort by: Date Name

Date	Empty Column	Title
4/3/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 4/3/2020 4/3/2020 7:00:00 AM 4/3/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 4/3/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
4/17/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 4/17/2020 4/17/2020 7:00:00 AM 4/17/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 4/17/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
5/1/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 5/1/2020 5/1/2020 7:00:00 AM 5/1/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 5/1/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
5/15/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 5/15/2020 5/15/2020 7:00:00 AM 5/15/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 5/15/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
6/5/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 6/5/2020 6/5/2020 7:00:00 AM 6/5/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 6/5/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
6/19/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 6/19/2020 6/19/2020 7:00:00 AM 6/19/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 6/19/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
7/3/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 7/3/2020 7/3/2020 7:00:00 AM 7/3/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 7/3/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
7/17/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 7/17/2020 7/17/2020 7:00:00 AM 7/17/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 7/17/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
8/7/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 8/7/2020 8/7/2020 7:00:00 AM 8/7/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 8/7/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
8/21/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 8/21/2020 8/21/2020 7:00:00 AM 8/21/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 8/21/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
9/4/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 9/4/2020 9/4/2020 7:00:00 AM 9/4/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 9/4/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
9/18/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 9/18/2020 9/18/2020 7:00:00 AM 9/18/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 9/18/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
10/2/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 10/2/2020 10/2/2020 7:00:00 AM 10/2/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 10/2/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
10/16/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 10/16/2020 10/16/2020 7:00:00 AM 10/16/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 10/16/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
11/6/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 11/6/2020 11/6/2020 7:00:00 AM 11/6/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 11/6/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
11/20/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 11/20/2020 11/20/2020 7:00:00 AM 11/20/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 11/20/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
12/4/2020 7:00:00 AM	OhioHealth Molecular Tumor Board 2020 - 12/4/2020 12/4/2020 7:00:00 AM 12/4/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board 2020 - 12/4/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology
12/18/2020 7:00:00 AM	OhioHealth Molecular Tumor Board - 12/18/2020 12/18/2020 7:00:00 AM 12/18/2020 8:00:00 AM 15 OhioHealth Arthur G.H. Bing, MD, Cancer Center False MM/DD/YYYY	OhioHealth Molecular Tumor Board - 12/18/2020 The OhioHealth Molecular Tumor Board (MTB) occurs biweekly. The MTB is multidisciplinary in nature, with contributions from pharmacy, medical oncology, gynecologic oncology, pathology, genetics, research, and more. Oncologists submit referrals to the MTB at their discretion after genomic testing has been conducted. Patent cases are reviewed at the MTB to identify/analyze genomic alterations and possible treatment options or additional testing/assessment. Location: OhioHealth Arthur G.H. Bing, MD, Cancer Center Specialties: Oncology, Nurse Practitioners, Pharmacists, Physician Assistants, Academic/Research, Medical Genetics and Genomics, Hematology, Gynecologic Oncology, Pathology, Hematopathology, Molecular Genetic Pathology, Hematology-Oncology, Radiation Oncology, Surgical Oncology, Clinical Genetics, Oncology

Keywords:

RSS

ACPE

AMA

AOA 1-B

APRNPharma

CSWMFTB

NonPhy

ONA